|
P3-122 P-T03F-2588
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Microneedle-assisted lymphatic delivery of a natural immune modulator toxin for enhanced cancer immunotherapy
Suyeon Lim
|
|
P3-123 P-T03C-0504
Biomaterials for theranostics
-
Drug delivery
Fine-Tuning Liposomal Membrane Elasticity for Improved Biodistribution and Anti-Inflammatory Efficacy in Systemic Rheumatoid Arthritis Treatment
Dahwun Kim
|
|
P3-124 P-T03F-2929
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Application of Microneedle-directed drug delivery in Lymph Nodes for Tumor Chemoimmunotherapy for metastatic cancer
BYUNG DEOK KIM
|
|
P3-125 P-T03C-0652
Biomaterials for theranostics
-
Drug delivery
Healing Patch: Copolymerization of a Regenerative Drug During Microneedle Production for Targeted Tissue Regeneration
Solbi Park
|
|
P3-126 P-T03C-3909
Biomaterials for theranostics
-
Drug delivery
Controlling Drug Release Kinetics via Polydopamine Nanocarriers of Different Sizes
Hyeju Han
|
|
P3-127 P-T03F-2367
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Development of an adapter Chimeric Antigen Receptor (CAR) system using recombinant fusion CAR protein with antibody binding domain
Suyeon Lim
|
|
P3-128 P-T03C-0561
Biomaterials for theranostics
-
Drug delivery
Nanoparticles capable of combating multidrug-resistant tumor cells
Young A KIM
|
|
P3-129 P-T03F-2592
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Kinetically activating nanoadjuvant that dynamically coordinates innate immune stimuli enhances cancer immunotherapy and reduces immune cell exhaustion
Seung Mo Jin
|
|
P3-130 P-T03E-0667
Biomaterials for theranostics
-
Gene therapy
Overcoming Gene Payload Limitation of Adeno-Associated Virus: Supra-structured AAVs Constructed by Polyphenols
Yu Ri Nam
|
|
P3-131 P-T03C-0614
Biomaterials for theranostics
-
Drug delivery
Fe3O4-based magnetic electrospun nanofiber incorporated with ammonium bicarbonate for hyperthermia treatment and tumor-triggered controlled drug release
Quynh Quang Nhat Vo
|
|
P3-132 P-T03E-0640
Biomaterials for theranostics
-
Gene therapy
Patient convenience improved gene therapy to Manage hyperglycemia in Type 2 diabetes
Jeong Man An
|
|
P3-133 P-T03D-0457
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Tumor microenvironment-responsive exosomes for mitochondria-targeted sonodynamic therapy and cellular energy-depleting chemotherapy
Binh T. T. Pham
|
|
P3-134 O-T03D-3508
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Amplification of production yield and therapeutic efficacy of extracellular vesicles from stem cells via uniformly controlled shear stress
Wu Young Kang
|
|
P3-135 O-T03D-0657
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Exosomes from epidural fat-derived immortalized MSCs increase osteoblast differentiation
Yoing-Ju Lim
|
|
P3-136 P-T03C-4022
Biomaterials for theranostics
-
Drug delivery
An Antibody-CRISPR/Cas Conjugates Platform for Target-Specific Delivery and Gene Editing in Cancer
Seungju Yang
|
|
P3-137 O-T03F-0806
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Modeling of ECM-mimicking system using elongated iron-based magnetic nanomaterials for modulating immune response mechanism
Nayeon Kang
|
|
P3-138 P-T03A-3809
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Tumor-draining lymph node-targeted delivery of TLR7/8 agonist via sphingomyelin nanoparticles for improved cancer vaccination
Hyeonjeong Han
|
|
P3-139 P-T03D-2190
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Proteomic profiling of circulating plasma extracellular vesicles unveils novel sarcopenia biomarkers in humans
Jiyeon Kim
|
|
P3-140 E-T03E-3321
Biomaterials for theranostics
-
Gene therapy
Development of LNP-Exosome hybrid system for targeted pancreas KRASG12D oncogene silencing and its application toward gemcitabine chemotherapy
Heewon Park
|
|
P3-141 P-T03F-3415
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Anti-inflammation effect of polyethylene glycol-phospholipid nanoparticles by regulating macrophage polarization
Sun Woo Um
|
|
P3-142 O-T03F-0747
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Dynamic manipulation of submolecular ligand availability for immunoregulation of macrophage
Yuri Kim
|
|
P3-143 P-T03F-3634
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Treatment of severe infectious respiratory diseases via DNase-1 coated 25-hydroxycholesterol nanovesicle mediated sivelestat delivery
Donghyuk Seo
|
|
P3-144 P-T03C-1160
Biomaterials for theranostics
-
Drug delivery
Antifouling mesoporous organosilica nanoparticles for cancer therapy: inhibition of protein corona formation
Gyeongseok Yang
|
|
P3-145 P-T03C-4036
Biomaterials for theranostics
-
Drug delivery
Novel drug development system: Development of an electrical cell viability monitoring device based on drug-loaded cancer cell targeting aptamer
Nayeon Kwon
|
|
P3-146 P-T03E-4069
Biomaterials for theranostics
-
Gene therapy
Targeting both tumor-cell and tumor-associated macrophage for genome editing-based reversal of cancer immunosuppression
Seungcheol Kim
|
|
P3-147 E-T03D-1870
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Elevating Treatment Response Monitoring in Cancer Immunotherapy: Avidity-Based PD-L1-Exosome Capture with Dendrimer-Peptide Conjugates
Dongjun Shin
|
|
P3-148 P-T03F-3344
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Laser triggered nitric oxide releasing hydrogel strengthens antitumor immune response through tumor collagen depletion during NIR laser assisted photoimmunotherapy
Adityanarayan Mohapatra
|
|
P3-149 P-T03C-4064
Biomaterials for theranostics
-
Drug delivery
A study on the possibility of drug delivery biomaterials using porous structures of diatom
Daeryul Kwon
|
|
P3-150 P-T03E-4119
Biomaterials for theranostics
-
Gene therapy
Bi-specific Chimeric Antigen Receptor Augments NK-92 Immune Cell Therapy for Ovarian Cancer
Jee Young Chung
|
|
P3-151 P-T03C-4117
Biomaterials for theranostics
-
Drug delivery
Effective Delivery of CRISPR/Cas9 Ribonucleoprotein Using Controlled Ionizable Lipid Nanoparticles for Gene Editing
San Hae Im
|
Login
